Table 4.
Factors associated with PDR among cART-naïve HIV infected children, Ethiopia, 2018–2019.
| Variable | Number Missing | Any Resistance | p Value | |
|---|---|---|---|---|
| Yes (N = 8) | No (N = 49) | |||
| Age in years, median (IQR) | 0 | 5 (0.3–10) | 8 (5–12) | 0.06 |
| Sex (% Male) | 0 | 4 (57.1) | 24 (51.1) | 0.54 |
| WAZ, median (IQR) | 23 | −1.6 (−2.8–(−0.9)) | −1.9 (−2.9–(−0.9)) | 0.91 |
| HAZ, median (IQR) | 7 | −1.8 (−1.9–(−0.7)) | −1.6 (−3.0–(−0.7)) | 0.62 |
| BAZ, median (IQR) | 7 | −1.4 (−2.2–(−1.3)) | −1.2 (−2.2–(−0.5)) | 0.41 |
| CD4, median (IQR), cells/mm3 | 33 | 267 (217–317) | 370 (161–788) | 0.53 |
| Log10 pVL, median (IQR) copies/mL | 6 | 4.3 (4.1–4.8) | 4.2 (3.8–5.0) | 0.47 |
| WHO clinical stage, N (%) 1 2 3 4 |
4 |
1 (25) 2 (25.0) 4 (50) 0 (0) |
15 (30.6) 10 (20.4) 19 (38.8) 2 (4.1) |
0.71 |
IQR—interquartile range; ALT—alanine aminotransferase; AST—aspartate aminotransferase; HCT—hematocrit; WAZ—weight-for-age Z score; HAZ—height-for-age Z score; BAZ—body mass index-for-age Z score; WHO—World Health Organization.